Virtus Investment Advisers’s West Pharmaceutical WST Stock Holding History

Virtus Investment Advisers’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.14M	Buy	+5,965	New	+$1.82M	0.5%	30
2026 Q1	–	Sell	-6,728	Closed	-$1.85M	–	494
2025 Q4	$1.85M	Buy	+6,728	New	+$1.84M	0.5%	70
2024 Q1	–	Sell	-1,383	Closed	-$487K	–	385
2023 Q4	$487K	Hold	1,383	–	–	0.36%	86
2023 Q3	$519K	Hold	1,383	–	–	0.35%	74
2023 Q2	$529K	Hold	1,383	–	–	0.36%	83
2023 Q1	$479K	Sell	1,383 -47	-3%	-$13.7K	0.34%	96
2022 Q4	$337K	Sell	1,430 -389	-21%	-$92.2K	0.22%	139
2022 Q3	$448K	Buy	+1,819	New	+$554K	0.21%	92

Other funds holding WST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Virtus Investment Advisers's WST Position: Q2 2026 in Review

Virtus Investment Advisers opened a new position in West Pharmaceutical (WST) in Q2 2026: 5,965 shares worth $2.14M. The stake represents 0.5% of the portfolio and ranks #30 among its holdings. This is a return to the name: Virtus Investment Advisers previously reported a position in WST as recently as Q4 2025.

Virtus Investment Advisers first reported a position in WST in Q3 2022 and has held it in 8 quarters since. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

Virtus Investment Advisers held 5,965 shares of West Pharmaceutical worth $2.14M as of Q2 2026.
West Pharmaceutical was a new Virtus Investment Advisers position in Q2 2026.
West Pharmaceutical made up 0.5% of Virtus Investment Advisers's portfolio in Q2 2026, its #30 holding.
Virtus Investment Advisers first reported a position in West Pharmaceutical in Q3 2022 and has held it in 8 quarters since.
831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Virtus Investment Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.